Home Newsfeeds Deutsche Bank Maintains Hold on Stanley Black & Decker, Lowers Price Target to $90

Deutsche Bank Maintains Hold on Stanley Black & Decker, Lowers Price Target to $90

Deutsche Bank analyst Nicole Deblase maintains Stanley Black & Decker (NYSE:SWK) with a Hold and lowers the price target from $111 to $90.

byBenzinga Newsdesk

October 13, 2022

1 minute read

Deutsche Bank analyst Nicole Deblase maintains Stanley Black & Decker (NYSE:SWK) with a Hold and lowers the price target from $111 to $90.

General Dynamics Bags $218M Contract To Expand Artillery Production

By Lekha Gupta

October 3, 8:53 AM

General Dynamics Corporation (NYSE: GD) business unit, General Dynamics Ordnance and Tactical Systems (OTS), won an initial task contract worth $218 million for

Legal
News

Pilots Ratify 2-Year Contract Extension; New Agreement Extends Term Of UPS Pilot Contract Until September 1, 2025

By Benzinga Newsdesk

August 12, 11:55 AM

-Reuters

UPS

The GEO Group Q2 AFFO $0.69 Up From $0.58 YoY, Sales $588.20M Beat $561.50M Estimate

By Benzinga Newsdesk

August 2, 6:44 AM

The GEO Group (NYSE: GEO) reported quarterly earnings of $0.69 per share. This is a 18.97 percent increase over earnings of $0.58 per share from the same period last year.

GEO

Analyst Ratings

Morgan Stanley Maintains Overweight Rating for Axonics: Here’s What You Need To Know

By Benzinga Insights

August 2, 12:20 PM

Morgan Stanley has decided to maintain its Overweight rating of Axonics (NASDAQ:AXNX) and raise its price target from $73.00 to $80.00. Shares of Axonics are trading up 5.7% over the last 24 hours, at $70.46 per share. A move to $80.00 would account for a 13.54% increase from the current share price.

AXNX

Deutsche Bank Maintains Hold on Stanley Black & Decker, Lowers Price Target to $90

Related Posts

General Dynamics Bags $218M Contract To Expand Artillery Production

Pilots Ratify 2-Year Contract Extension; New Agreement Extends Term Of UPS Pilot Contract Until September 1, 2025

The GEO Group Q2 AFFO $0.69 Up From $0.58 YoY, Sales $588.20M Beat $561.50M Estimate

Morgan Stanley Maintains Overweight Rating for Axonics: Here’s What You Need To Know